Positive Late-breaking Clinical Trial Data for the EkoSonic™ Endovascular System Presented at VIVA21 - Medical Device News Magazine
Exposing inefficiencies in clinical trial design – Clinical Trials
Groundbreaking' endovascular clinical trial results detailed - Page 4 of 6 - Medical Design and Outsourcing
VIVA 2014 Announces Clinical Trial Results | DAIC
Veeva: Not Enough Risk In This Winning SaaS Platform (NYSE:VEEV) | Seeking Alpha
PQ Bypass Releases Positive 24-Month Data from the DETOUR1 Clinical Trial for Percutaneous Femoropopliteal Bypass at VIVA 2020 | Business Wire
Late-Breaking Clinical Trials | VIVA
FDA Pivotal Clinical Trial Design and Beyond | tctmd.com
Clinical Trial Results - Eluvia Drug-Eluting Stent - Boston Scientific
Future of Patient Centricity within Clinical Trials
Summary of paracrine factors used in clinical trials for myocardial... | Download Table
Veeva Systems
VIVA News - Results from 16 Significant Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA21 | VIVA
Week Note 2017-10 | MIT Collaborative Initiatives
VIVA News - New Unpublished Vascular Clinical Trial Results Announced at VIVA 18 | VIVA
VIVA 2019 Late-breaking Clinical Trials | DAIC
A Practical Guide to Human Research and Clinical Trials: 9781466591172: Medicine & Health Science Books @ Amazon.com
Transplant Institute Clinical Trials & Grants | NYU Langone Health
VIVA News - Five More Late-Breaking Clinical Trials Announced at VIVA19 | VIVA
12-Month data from PREVEIL study of SurVeil DCB presented at VIVA - Interventional News
Arthrosi Therapeutics Released Phase 2 Clinical Data of AR882
Presentation to the Clinical Trials Transformation Initiative Steering Committee – Clinical Trials
Groundbreaking Endovascular Clinical Trial Results Announced At VIVA 18
Trials Testing Oral Varoglutamstat for Alzheimer's Enrolling in US, Europe
The Latest Vascular Interventional Clinical Data Presented at VIVA 2020 | DAIC
Second Day of Late-Breaking Clinical Trial Results at VIVA 14
